Multiple myeloma uses a trick akin to a wolf in sheep's clothing to grow in and spread to new bone sites. By overexpressing Runx2, a gene that normally is a master regulator of bone formation, the cells of this largely incurable ...
Jul 10, 2015
0
40
In a highly successful, first-of-its-kind endeavor, a multidisciplinary team of University of Wisconsin-Madison researchers have created a "tumor in a dish:" an ex vivo microenvironment that can accurately anticipate a multiple ...
Jun 12, 2015
0
24
In some ways, studying the genetics of cancer has been like examining the individual tiles on a mosaic, says David C. Schwartz, a professor of genetics and chemistry at the University of Wisconsin-Madison. To make his point, ...
Jun 8, 2015
0
44
(HealthDay)—A two-pronged immune-boosting drug could provide new hope for people stricken with multiple myeloma, a cancer of the blood and bone marrow, according to clinical trial findings.
Jun 2, 2015
0
20
In a report on what is believed to be the first small clinical trial of its kind, researchers at the Johns Hopkins Kimmel Cancer Center say they have safely used immune cells grown from patients' own bone marrow to treat ...
May 20, 2015
0
67
Researchers have designed a nanoparticle-based therapy that is effective in treating mice with multiple myeloma, a cancer of immune cells in the bone marrow.
May 19, 2015
0
33
A new kind of immune therapy has shown promise against the third most common blood cancer, multiple myeloma, researchers said Wednesday.
May 13, 2015
0
6
Innsbruck scientists grow miniature tumours on eggshell membranes. The EU project OPTATIO succeeded in developing an urgently needed drug screening system for bone marrow cancer.
May 4, 2015
0
14
An update search enlarged the pool of study data, but did not change the content of the conclusion of the benefit assessment of stem cell transplantation (SCT) for multiple myeloma conducted in 2012. Overall, the evidence ...
Apr 29, 2015
0
4
Amgen Inc., the Thousand Oaks, Calif., biotech giant, said Sunday a new study has found its cancer drug Kyprolis is far more effective in treatment of relapsed multiple myeloma than its chief rival.
Mar 3, 2015
0
6
